FSA
TEVA icon

Financial Sense Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Financial Sense Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$714K – 118
2023
Q3 		– Hold
0
– – – 68
2023
Q2 		– Hold
0
– – – 67
2022
Q3 		– Hold
0
– -$526K – 97
2022
Q2 		– Hold
0
– – – 71

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Financial Sense Advisors's TEVA Position: Q2 2026 in Review

Financial Sense Advisors reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 1.3% in Q2 2026, selling an estimated $71.6K and leaving 163,086 shares worth $5.53M. The position accounts for 1.09% of the portfolio, ranked #22.

Financial Sense Advisors first reported a position in TEVA in Q2 2017 and has held it in 35 quarters since. The position peaked at $23.5M in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Financial Sense Advisors held 163,086 shares of Teva Pharmaceutical Industries Limited worth $5.53M as of Q2 2026.
  • Financial Sense Advisors sold 2,150 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $71.6K.
  • Teva Pharmaceutical Industries Limited made up 1.09% of Financial Sense Advisors's portfolio in Q2 2026, its #22 holding.
  • Financial Sense Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2017 and has held it in 35 quarters since.
  • Financial Sense Advisors's Teva Pharmaceutical Industries Limited position peaked at $23.5M in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Financial Sense Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.